Gene · 2303
Papers2,402
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,402
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SCTR-Expressing Astrocyte-Serotonergic Neuron Signaling Drives Sexual Dimorphism in Depression Through KAT7/H4ac-Foxc2 Epigenetic Axis in an AMPK-Dependent Manner. | Adv Sci (Weinh) | 2026 | 42801528 | PubTator, text mining | PubMed |
| Molecular Distinctions, Diagnosis, and Mechanism-Based Therapies in Lipedema and Obesity. | Curr Issues Mol Biol | 2026 | 42793248 | PubTator, text mining | PubMed |
| Engineering lymphatic collecting vessel phenotypes through combined hyaluronic acid cues and oscillatory shear stress. | Cell Rep Methods | 2026 | 42697195 | PubTator, text mining | PubMed |
| Transcriptomic profiling of thyroid eye disease orbital fibroblasts identifies sorafenib as a novel therapeutic. | Front Endocrinol (Lausanne) | 2026 | 42688036 | PubTator, text mining | PubMed |
| Restoration of oscillatory shear stress in humans activates an endothelial protective genetic program and prevents DVT. | Blood | 2026 | 42611796 | PubTator, text mining | PubMed |
| Yellow Nail Syndrome in Childhood: A Case Report Highlighting Diagnostic Challenges and the Possible Role of Nail Development-Related Genetic Variants. | Skin Appendage Disord | 2026 | 42610102 | PubTator, text mining | PubMed |
| Out"FOX"ing cancer: the implications of FOXC2 as a putative predictive biomarker for cancer immunotherapy. | Front Med (Lausanne) | 2026 | 42454125 | PubTator, text mining | PubMed |
| Procr+ endothelial progenitor cells govern hematopoiesis through fine-tuning mesenchymal stem cell niche signals. | Blood | 2026 | 42101967 | PubTator, text mining | PubMed |
| The role of the cardiac lymphatic system in heart failure "reverse remodeling": from developmental signals to druggable targets. | Front Immunol | 2026 | 42099625 | PubTator, text mining | PubMed |
| FOXC2 represses NFAT1-dependent transcription through a DNA-facilitated protein-protein interaction. | Nucleic Acids Res | 2026 | 42023653 | PubTator, text mining | PubMed |
| Gelatinous drop-like amyloid in FOXC2 distichiasis syndrome: a case report. | BMC Ophthalmol | 2026 | 41965558 | PubTator, text mining | PubMed |
| Vasculogenic tissue nanotransfection accelerates functional recovery after peripheral nerve injury. | Sci Adv | 2026 | 41950328 | PubTator, text mining | PubMed |
| Time and architecture: the next two dimensions of microphysiological systems. | NPJ Biomed Innov | 2026 | 41907168 | PubTator, text mining | PubMed |
| Fueling or Fighting Cancer? The Thermogenic Paradox of Brown Adipose Tissue. | Curr Obes Rep | 2026 | 41848823 | PubTator, text mining | PubMed |
| BCL11B enhancer hijacking by t(14;16)(q32;q24) translocation defines a novel high-risk subtype of T-ALL. | Blood | 2026 | 41790573 | PubTator, text mining | PubMed |
| Mass spectrometry-based multi-omics analysis elucidates immune microenvironmental characteristics and the risk of distant metastasis in N1c colorectal cancer. | Front Immunol | 2026 | 41782869 | PubTator, text mining | PubMed |
| Benign, persistent, and invasive: mechanistic and translational approaches to middle‑ear cholesteatoma. | Explor Target Antitumor Ther | 2026 | 41767763 | PubTator, text mining | PubMed |
| The emerging role of m6A methylation in prostate-related diseases: mechanisms and clinical implications. | Front Immunol | 2026 | 41766860 | PubTator, text mining | PubMed |
| Safeguarding lymphatic identity: cooperative Erg and Fli1 activity in lymphatic vascular homeostasis. | J Clin Invest | 2026 | 41766660 | PubTator, text mining | PubMed |
| m5C: Novel Diagnostic and Drug Repurposing Targets for Nonalcoholic Steatohepatitis. | Int J Genomics | 2026 | 41755884 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2303/papers